Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

USP Potency Adjusted Bovine Mucosal Heparins (BMH) Are Comparable to Porcine Mucosal Heparin (PMH) at Equivalent Levels

Ahmed Kouta, Walter Jeske, PhD, Rick Duff, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 165.

https://doi.org/10.1182/blood-2019-131943

Published: 2019

Journal Articles

Safety of Direct-Acting Oral Anticoagulants Versus Enoxaparin in Patients with Primary and Metastatic Brain Tumors

Brian J. Carney, MD, Erik J. Uhlmann, MD, Maneka Puligandla, MS, Charlene Mantia, MD, Griffin M. Weber, MD PhD, Donna S Neuberg, ScD, Jeffrey I. Zwicker, MD

Blood (2018) 132 (Supplement 1): 2521.

https://doi.org/10.1182/blood-2018-99-115666

Published: 2018

Journal Articles

Anticoagulating patients with high-risk acquired thrombophilias

Leslie Skeith

Blood (2018) 132 (21): 2219–2229.

https://doi.org/10.1182/blood-2018-05-848697

Published: 2018

Journal Articles

An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients

Blood (2017) 130 (Supplement 1): 626.

https://doi.org/10.1182/blood.V130.Suppl_1.626.626

Published: 2017

Journal Articles

Dabigatran Is Associated with a Significantly Lower Risk of Abnormal Uterine Bleeding Than Warfarin in Female Patients of Childbearing Age with Venous Thromboembolism

Melanie Ferreira, Frederikus A Klok, Martin Feuring, Mandy Fraessdorf, Jörg Kreuzer, MD, Menno V Huisman

Blood (2016) 128 (22): 140.

https://doi.org/10.1182/blood.V128.22.140.140

Published: 2016

Journal Articles

Treatment of Acute VTE with Rivaroxaban - Results of the Prospective Dresden Noac Registry (NCT01588119)

Loretta Keller, Sandra Marten, MD, Judith Hecker, Sebastian Werth, MD, Luise Tittl, B.Sc., Jan Beyer-Westendorf, MD

Blood (2016) 128 (22): 2618.

https://doi.org/10.1182/blood.V128.22.2618.2618

Published: 2016

Journal Articles

Post-Operative Anticoagulation and the Incidence of Left Ventricular Assist Device Thrombosis

David M. Nemer, MD, Garrick C. Stewart, MD MPH, Maneka Puligandla, MS, Donna S. Neuberg, ScD, Jean M. Connors, MD

Blood (2016) 128 (22): 2620.

https://doi.org/10.1182/blood.V128.22.2620.2620

Published: 2016

Journal Articles

Non-Warfarin Oral Anticoagulants in Anti-Phospholipid Syndrome

Paul Kunk, MD, B. Gail Macik, MD, Melissa Rice, MD

Blood (2015) 126 (23): 1133.

https://doi.org/10.1182/blood.V126.23.1133.1133

Published: 2015

Journal Articles

A Humanized Anti FcγRIIa Scfv Inhibits Platelet Activation, Aggregation and Thrombus Formation in Heparin-Induced Thrombocytopenia (HIT)

Jose Perdomo, PhD, Jaa Yien New, PhD, Zohra Ahmadi, Xing-Mai Jiang, PhD, Beng H Chong, MBBS, PhD

Blood (2015) 126 (23): 10.

https://doi.org/10.1182/blood.V126.23.10.10

Published: 2015

Journal Articles

Staged Interventions to Improve Quality and Reduce Cost of Care in Patients with Suspected Heparin-Induced Thrombocytopenia

Bethany T Samuelson, MD, Meredith Holmes, PharmD, Andrew White, MD, Emily Glynn, MD, Daniel B Martin, MD, David Garcia, MD, Janet Kelly, PharmD, Ann Kathryn Wittkowsky, PharmD

Blood (2015) 126 (23): 2262.

https://doi.org/10.1182/blood.V126.23.2262.2262

Published: 2015

Journal Articles

Characteristics and Treatment Patterns of Patients with Deep Vein Thrombosis and/or Pulmonary Embolism in the US Hospital Setting

Matthew Sussman, Jonathan Lim, Cheng Wang, Mark Friedman, MD, Stephen Sander, Robert Griffiths

Blood (2015) 126 (23): 2061.

https://doi.org/10.1182/blood.V126.23.2061.2061

Published: 2015

Journal Articles

Inappropriate Listing of Heparin As an Allergy in the Electronic Medical Record Due to Misdiagnosis of Heparin-Induced Thrombocytopenia: Frequency and Consequences

Christine M. McMahon, MD, Adam Cuker, MD MS

Blood (2015) 126 (23): 3479.

https://doi.org/10.1182/blood.V126.23.3479.3479

Published: 2015

Journal Articles

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis

Aaron P Soff, Judy Dong, MD, Aiqi Dong, Sean Devlin, PhD, Simon Mantha, MD MPH, Rekha Parameswaran, MD, Gerald A Soff, MD

Blood (2015) 126 (23): 2068.

https://doi.org/10.1182/blood.V126.23.2068.2068

Published: 2015

Journal Articles

A Universal Heparin Antidote with Negligible Effect on Fibrin(ogen) and Plasma Coagulation

Manu Thomas Kalathottukaren, PhDcandidate, Rajesh A Shenoi, PhD, Lai FL Benjamin, MSc, Fred Rosell, PhD, Jayachandran N Kizhakkedathu, PhD, Edward L.G. Pryzdial, PhD

Blood (2014) 124 (21): 4231.

https://doi.org/10.1182/blood.V124.21.4231.4231

Published: 2014

Journal Articles

Antithrombotic Treatment and Outcomes of Splanchnic Vein Thrombosis in an International Prospective Registry: Results of 2-Year Follow-up

Walter Ageno, MD, Nicoletta Riva, Sam Schulman, MD PhD, Jan Beyer-Westendorf, MD, Soo-Mee Bang, Marco Senzolo, Elvira Grandone, Giovanni Barillari, Matteo Di Minno, Rita Duce, Alessandra Malato, Rita Santoro, Daniela Poli, Peter Verhamme, MD PhD, Ida Martinelli, Pieter W. Kamphuisen, MD PhD, Francesco Dentali, MD

Blood (2014) 124 (21): 592.

https://doi.org/10.1182/blood.V124.21.592.592

Published: 2014

Journal Articles

Use Of Fondaparinux For Venous Thromboembolism Prophylaxis In Critically Ill Adult Patients With Moderate Renal Insufficiency

Anjan J Patel, MD, Marc Zumberg, MD, Jessica Cope, PharmD, Jennifer Bushwitz, PharmD, Abigail D Antigua, PharmD

Blood (2013) 122 (21): 4806.

https://doi.org/10.1182/blood.V122.21.4806.4806

Published: 2013

Journal Articles

Indirect Comparison Of Dabigatran, Rivaroxaban and Apixaban For Venous Thromboembolic Disease

Simon Mantha, MD, MPH, Jack Ansell, MD

Blood (2013) 122 (21): 3640.

https://doi.org/10.1182/blood.V122.21.3640.3640

Published: 2013

Journal Articles

Patient-Reported Treatment Satisfaction with Oral Rivaroxaban Versus Standard Therapy in the Treatment of Acute Symptomatic Pulmonary Embolism

Martin Prins, MD, PhD, Luke Bamber, Stefan Cano, Maria Wang, Anthonie WA Lensing, Rupert Bauersachs

Blood (2012) 120 (21): 1163.

https://doi.org/10.1182/blood.V120.21.1163.1163

Published: 2012

Journal Articles

Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry

Blood (2012) 120 (21): 499.

https://doi.org/10.1182/blood.V120.21.499.499

Published: 2012

Journal Articles

Relationship Between Subtherapeutic Warfarin Anticoagulation and the Development of Post Thrombotic Syndrome After a First Unprovoked Deep Vein Thrombosis: Results From the REVERSE Cohort Study

Rufaro S. Chitsike, MD, Susan R. Kahn, MD, MSc, Michael J. Kovacs, MD, FRCPC, Marisol T. Betancourt, MD, MSc, Philip S Wells, David Anderson, MD, Isabelle Chagnon, MD, Gregoire Le Gal, MD, PhD, Susan Solymoss, MD, Mark A. Crowther, MD, FRCPC, Arnaud Perrier, Richard H. White, MD, Linda Vickars, Tim Ramsay, Marc A. Rodger, MD, FRCPC

Blood (2011) 118 (21): 712.

https://doi.org/10.1182/blood.V118.21.712.712

Published: 2011

NARROW

USP Potency Adjusted Bovine Mucosal Heparins (BMH) Are Comparable to Porcine Mucosal Heparin (PMH) at Equivalent Levels

Safety of Direct-Acting Oral Anticoagulants Versus Enoxaparin in Patients with Primary and Metastatic Brain Tumors

Anticoagulating patients with high-risk acquired thrombophilias

An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients

Dabigatran Is Associated with a Significantly Lower Risk of Abnormal Uterine Bleeding Than Warfarin in Female Patients of Childbearing Age with Venous Thromboembolism

Treatment of Acute VTE with Rivaroxaban - Results of the Prospective Dresden Noac Registry (NCT01588119)

Post-Operative Anticoagulation and the Incidence of Left Ventricular Assist Device Thrombosis

Non-Warfarin Oral Anticoagulants in Anti-Phospholipid Syndrome

A Humanized Anti FcγRIIa Scfv Inhibits Platelet Activation, Aggregation and Thrombus Formation in Heparin-Induced Thrombocytopenia (HIT)

Staged Interventions to Improve Quality and Reduce Cost of Care in Patients with Suspected Heparin-Induced Thrombocytopenia

Characteristics and Treatment Patterns of Patients with Deep Vein Thrombosis and/or Pulmonary Embolism in the US Hospital Setting

Inappropriate Listing of Heparin As an Allergy in the Electronic Medical Record Due to Misdiagnosis of Heparin-Induced Thrombocytopenia: Frequency and Consequences

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis

A Universal Heparin Antidote with Negligible Effect on Fibrin(ogen) and Plasma Coagulation

Antithrombotic Treatment and Outcomes of Splanchnic Vein Thrombosis in an International Prospective Registry: Results of 2-Year Follow-up

Use Of Fondaparinux For Venous Thromboembolism Prophylaxis In Critically Ill Adult Patients With Moderate Renal Insufficiency

Indirect Comparison Of Dabigatran, Rivaroxaban and Apixaban For Venous Thromboembolic Disease

Patient-Reported Treatment Satisfaction with Oral Rivaroxaban Versus Standard Therapy in the Treatment of Acute Symptomatic Pulmonary Embolism

Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry

Relationship Between Subtherapeutic Warfarin Anticoagulation and the Development of Post Thrombotic Syndrome After a First Unprovoked Deep Vein Thrombosis: Results From the REVERSE Cohort Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only